Viewing Study NCT03463460


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2025-12-26 @ 12:25 AM
Study NCT ID: NCT03463460
Status: RECRUITING
Last Update Posted: 2025-08-24
First Post: 2018-02-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer
Sponsor: Dwight Owen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module